EP21: From Molecule to Market: Exploring the Journey from Discovery to Commercialization

In this episode of Protein Production Technology International, industry experts discuss the challenges of scaling alternative proteins from lab to market. The panel explores key bottlenecks, including strain optimization, downstream processing, and securing the right contract manufacturers. They highlight the importance of early techno-economic analysis, batch-to-batch consistency, and leveraging predictive tools for strain engineering. Sustainability remains a priority, with discussions on upcycling side streams and balancing profitability. Regulatory hurdles and geopolitical factors also shape commercialization strategies, with insights on diversifying markets and alternative revenue streams. The conversation underscores the need for collaboration, strategic partnerships, and adaptable business models to navigate the evolving landscape of alternative protein production.

Creators and Guests

Adam Leman
Guest
Adam Leman
The Good Food Institute
Brian Jacobson
Guest
Brian Jacobson
Associate Director of Strategic Operations, Food Science and Human Nutrition, IBRL, University of Illinois Urbana-Champaign
Chris Saenz
Guest
Chris Saenz
Beckman Coulter Life Sciences
Kartheek Anekella
Guest
Kartheek Anekella
Global Marketing Manager, Food and Alternative Protein @ Pall Corporation
Mihir Pershad
Guest
Mihir Pershad
Founder & CEO @ Umami Bioworks
Simo Ellilä
Guest
Simo Ellilä
CEO & Co-founder @ Enifer
EP21: From Molecule to Market: Exploring the Journey from Discovery to Commercialization
Broadcast by